Eli Lilly plans to expand insulin access for diabetics, NCD therapies in India
With approximately 101 million individuals living with diabetes, increasing access to insulin and advanced treatments is ...
Hosted on MSN11d
Drug manufacturer Eli Lilly says two of its diabetes drugs are in short supply - as millions of patients face weeks of chaos
Prices of insulin have continued to climb, even though it is cheap to make – around $4. But when adjusted for inflation, Eli ...
Richmond Times-Dispatch12d
Petersburg drugmaker Civica misses target for selling cheap insulin
The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens.
Medscape14d
Insulin Detemir: A Long-Acting Insulin Product
a DB = double-blind, DM = diabetes mellitus, HbA 1c = glycosylated hemoglobin, MC = multicenter, NPH = isophane insulin human, NR = not recorded, OL = open-label, PG = parallel-group, R = randomized.
Medical News Today18d
4 natural ways to improve insulin sensitivity
High insulin sensitivity allows the body’s cells to use blood glucose more effectively, reducing blood sugar. Some lifestyle, self-care, and dietary changes may help increase insulin sensitivity.
BioSpace25d
Novo, Sanofi Hit With Anti-Competitive Probe in South Africa: Bloomberg
Months later, however, Novo announced that it would discontinue its long-acting insulin product Levemir, removing both the vials and pen from the market ... availability of two of its inulin ...
Independent Online25d
South African Competition Commission probes Novo Nordisk and Sanofi over insulin pen market
Aspen Pharmacare Holdings Ltd, Africa’s largest drugmaker, has a deal with Novo to make human insulin vials in South Africa, with local commercial production starting soon. “We are just trying ...
Daily Maverick25d
South African watchdog probes Novo Nordisk and Sanofi over insulin
South Africa's competition watchdog probes Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market South Africa’s competition watchdog is investigating ...
biznews.com25d
Novo’s insulin pen phase-out sparks CompCom probe as diabetes remains a silent killer among SA women
After a decade of being the primary supplier of human insulin pens in South Africa, Novo decided against bidding for the 2024 tender. Instead it decided to phase out the easy-to-use pens and tendered ...
News2426d
SA watchdog to probe global giants over insulin pens
After a decade of being the primary supplier of human insulin pens in South Africa, Novo decided against bidding for the 2024 tender. Instead, it decided to phase out the easy-to-use pens and tendered ...
Reuters26d
South African watchdog probes Novo Nordisk and Sanofi over insulin
March 4 (Reuters) - South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive practices in the human insulin pen market, the authority ...
Medscape26d
Patient Satisfaction and Costs Associated With Insulin Administered by Pen Device or Syringe During Hospitalization
A total of 94 patients were eligible for study inclusion and randomization from July 2005 through May 2006; 45 were randomized to the vial and syringe group and 49 were randomized to the insulin ...